Research & Development
We direct funding toward the most promising scientific work in alpha-gal syndrome — supporting investigators, helping move early ideas toward clinical study, and prioritizing research with a clear path to improving patients’ lives. Our focus is on better diagnostics, better treatments, and the long-term goal of a cure.

